Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. uri icon

authors

  • McClung, Michael R
  • Bonaca, Marc P
  • Wiviott, Stephen D
  • de Villiers, Tobias
  • Ling, Xu
  • Lippuner, Kurt
  • Nakamura, Toshitaka
  • Reginster, Jean-Yves
  • Rodriguez-Portales, Jose Adolfo
  • Roux, Christian
  • Zanchetta, José
  • O'Donoghue, Michelle L
  • Zerbini, Cristiano A F
  • Park, Jeong-Gun
  • Im, KyungAh
  • Cange, Abby
  • Grip, Laura T
  • Heyden, Norman
  • DaSilva, Carolyn
  • Cohn, Dosinda
  • Massaad, Rachid
  • Scott, Boyd B
  • Papapoulos, Socrates E
  • Verbruggen, Nadia
  • Gurner, Deborah
  • Miller, Deborah L
  • Blair, Micki L
  • Polis, Adam B
  • Stoch, S Aubrey
  • Santora, Arthur
  • Lombardi, Antonio
  • Leung, Albert T
  • Kaufman, Keith D
  • Bone, Henry
  • Sabatine, Marc S
  • Langdahl, Bente
  • Saag, Kenneth G
  • Reid, Ian R
  • Douglas P. Kiel, MD, MPH
  • Cavallari, Ilaria

publication date

  • October 31, 2019